We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
-2.81%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$93.9M
Cap. Flow
+$112M
Cap. Flow %
33.58%
Top 10 Hldgs %
28.51%
Holding
174
New
26
Increased
81
Reduced
34
Closed
27

Top Buys

Rank Stock Value
1
TEX icon
Terex
TEX
+$6.33M
2
HRI icon
Herc Holdings
HRI
+$6.32M
3
TKR icon
Timken Company
TKR
+$4.82M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
5
VMC icon
Vulcan Materials
VMC
+$4.35M

Top Sells

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$7.13M
2
FLR icon
Fluor
FLR
+$5.32M
3
FSS icon
Federal Signal
FSS
+$5.11M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.53M
5
ASND icon
Ascendis Pharma A/S
ASND
+$1.85M

Sector Composition

Rank Sector Weight
1 Industrials 43.38%
2 Healthcare 33.02%
3 Utilities 7.31%
4 Technology 5.91%
5 Financials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
76
KLA
KLAC
$278B
$1.43M 0.43%
21,020
+12,350
+142% +$890K
PFGC icon
77
Performance Food Group
PFGC
$17.6B
$1.31M 0.39%
+16,706
New +$1.39M
CYTK icon
78
Cytokinetics
CYTK
$10.9B
$1.31M 0.39%
32,588
-14,795
-31% -$680K
LOW icon
79
Lowe's Companies
LOW
$117B
$1.24M 0.37%
5,335
+3,702
+227% +$911K
JANX icon
80
Janux Therapeutics
JANX
$992M
$1.24M 0.37%
45,937
+40,714
+780% +$1.53M
DHR icon
81
Danaher
DHR
$144B
$1.22M 0.37%
5,964
-905
-13% -$198K
BWXT icon
82
BWX Technologies
BWXT
$15.7B
$1.2M 0.36%
12,186
+8,938
+275% +$970K
EW icon
83
Edwards Lifesciences
EW
$49.4B
$1.2M 0.36%
16,543
-5,092
-24% -$364K
CP icon
84
Canadian Pacific Kansas City
CP
$83.2B
$1.19M 0.36%
16,981
+10,070
+146% +$766K
DE icon
85
Deere & Co
DE
$161B
$1.13M 0.34%
2,397
+1,610
+205% +$753K
TER icon
86
Teradyne
TER
$50.5B
$1.12M 0.34%
13,611
+8,075
+146% +$903K
LRCX icon
87
Lam Research
LRCX
$392B
$1.12M 0.33%
15,384
+9,120
+146% +$718K
PODD icon
88
Insulet
PODD
$11.4B
$1.09M 0.32%
4,134
-1,251
-23% -$339K
MCK icon
89
McKesson
MCK
$98.5B
$1.06M 0.32%
+1,574
New +$973K
DXCM icon
90
DexCom
DXCM
$29.6B
$1.04M 0.31%
15,271
-13,372
-47% -$1.09M
WAT icon
91
Waters Corp
WAT
$36.2B
$1.04M 0.31%
2,816
+1,433
+104% +$555K
ASND icon
92
Ascendis Pharma A/S
ASND
$17.1B
$952K 0.28%
6,106
-12,934
-68% -$1.85M
ADI icon
93
Analog Devices
ADI
$183B
$941K 0.28%
4,664
+2,755
+144% +$595K
IDYA icon
94
IDEAYA Biosciences
IDYA
$3.47B
$921K 0.28%
56,204
+40,138
+250% +$855K
CNI icon
95
Canadian National Railway
CNI
$78.3B
$877K 0.26%
8,994
+5,320
+145% +$538K
DCI icon
96
Donaldson
DCI
$10.5B
$795K 0.24%
11,848
+7,030
+146% +$486K
USFD icon
97
US Foods
USFD
$21.4B
$780K 0.23%
+11,917
New +$814K
IONS icon
98
Ionis Pharmaceuticals
IONS
$8.99B
$759K 0.23%
25,141
-31,703
-56% -$1.04M
MASI
99
DELISTED
Masimo
MASI
$757K 0.23%
4,543
-5,037
-53% -$874K
MDGL icon
100
Madrigal Pharmaceuticals
MDGL
$12.8B
$755K 0.23%
2,278
-1,342
-37% -$441K
2 3
4
5 6

Similar funds

DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $3.08B AUM 12.02% 1-Year Est. Return

Tema ETFs's Q1 2025 Portfolio in Review

As of Q1 2025, Tema ETFs held 174 positions worth $335M, up 39% from $241M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tema ETFs deployed $112M of net new capital in Q1 2025, opening 26 new positions and adding to 81 existing holdings. Its largest new stake was Bristol-Myers Squibb: 75,050 shares worth $4.58M.

By sector, the portfolio is most concentrated in Industrials at 43% of assets, down from 46% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $2.53M trimmed.

  • Tema ETFs's largest Q1 2025 buy was Bristol-Myers Squibb: 75,050 shares worth $4.58M.
  • Tema ETFs added most to Terex in Q1 2025, an estimated $6.33M increase.
  • Tema ETFs's biggest Q1 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.53M.
  • Tema ETFs fully exited Primoris Services in Q1 2025, selling an estimated $7.13M.
  • Tema ETFs's ten largest holdings make up 29% of its $335M portfolio in Q1 2025.
  • Tema ETFs opened 26 new positions and closed 27 in Q1 2025.
  • Tema ETFs's portfolio value rose 39% quarter-over-quarter to $335M.

Based on Tema ETFs's 13F filing for Q1 2025, filed 14 May 2025.